MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc. Thousand Oaks, CA 91320-1799, NDC 55513-0206-01

Recall Number: D-0855-2022

Firm: Amgen, Inc.

Classification: Class II

Status: Terminated

Report Date: 20220518

Initiation Date: 20220502

Termination Date: 20221202

Defective container: loose crimp defect, potential loss of container integrity.

MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc. Thousand Oaks, CA 91320-1799, NDC 55513-0206-01